DANBURY, Conn., March 30, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today the appointment of Dr. Brian J.G. Pereira as board chairman effective immediately. Dr. Pereira has served on the board since November 2007. Dr. Charles A. Sanders, who served as chairman since March 2010 after joining the board in August 2006, will continue to serve as a board member pending his return from medical leave.
Dr. Sanders stated: "The board and I welcome Dr. Pereira as chairman. We are confident his leadership, experience and continued commitment will ensure the future success of our company."
Dr. Pereira stated: "I thank the board for their confidence in me as Biodel makes important steps forward in its development program. I join the board in thanking Dr. Sanders for his guidance and leadership."
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. For further information regarding Biodel, please visit the company's website at www.biodel.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements about future activities related to the clinical development plans for the company's drug candidates, including the potential timing, design and outcomes of clinical trials; and the company's ability to develop and commercialize product candidates. Forward-looking statements represent our